Utilizing this approach, patients with a CPVT diagnostic score of 3.5 (without genetic test results) exhibit a likelihood of CPVT1 (i.e., RyR2-mediated CPVT) of at least 60% [55]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.